ZBTB3: A Protein Interaction with NF-E2 and TGF-β Signaling Pathways

Target Name: ZBTB3

NCBI ID: G79842

ZBTB3

ZBTB3: A Protein Interaction with NF-E2 and TGF-β Signaling Pathways

ZBTB3 (Zinc Finger Transmembrane Binding Protein 3) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the ZNF2 family, which is known for its role in regulating gene expression and cell proliferation. ZBTB3 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of ZBTB3 is its ability to interact with various transcription factors, including nuclear factor E2 (NF-E2). NF-E2 is a transcription factor that has been shown to play a role in the regulation of gene expression and cell proliferation. By interacting with NF-E2, ZBTB3 has been shown to regulate the activity of NF-E2 and to influence the expression of genes that are important for cell growth, differentiation, and survival.

In addition to its role in regulating gene expression, ZBTB3 has also been shown to play a role in the regulation of cell signaling pathways. It is a member of the TGF-β pathway, which is a well-known pathway that is involved in the regulation of cell growth, differentiation, and survival. ZBTB3 has been shown to play a role in the regulation of TGF-β signaling by interacting with the protein Smad6.

The role of ZBTB3 in cell signaling pathways is further confirmed by its ability to regulate the activity of various signaling pathways, including the PI3K/Akt signaling pathway. PI3K is a protein that is involved in the regulation of cell signaling, including the regulation of cell growth and differentiation. Akt is a protein that is derived from the PI3K signaling pathway and is involved in the regulation of cell growth and survival. ZBTB3 has been shown to play a role in the regulation of PI3K/Akt signaling by interacting with the protein p110未.

In addition to its role in cell signaling pathways, ZBTB3 has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration and invasion. It is a member of the cadherin family, which is involved in the regulation of cell adhesion, and has been shown to play a role in the regulation of cadherin-based signaling pathways.

ZBTB3 has also been shown to play a role in the regulation of cellular processes such as cell death, apoptosis and autophagy. It is a member of the BCL-2 family, which is involved in the regulation of cell death and apoptosis, and has been shown to play a role in the regulation of BCL-2-mediated signaling pathways.

The potential clinical applications of ZBTB3 as a drug target or biomarker are vast. For example, ZBTB3 has been shown to be involved in the regulation of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ZBTB3 has also been shown to play a role in the regulation of various cellular processes, including cell signaling pathways, cell adhesion, migration and invasion, and cellular processes such as cell death, apoptosis and autophagy.

ZBTB3 has also been shown to be a potential biomarker for various diseases, including cancer. For example, ZBTB3 has been shown to be involved in the regulation of the growth and survival of various cancer cell lines, and has been shown to play a role in the regulation of the angiogenesis of cancer. ZBTB3 has also been shown to be involved in the regulation of the production of pro-inflammatory cytokines, which have been shown to play a role in the development

Protein Name: Zinc Finger And BTB Domain Containing 3

Functions: May be involved in transcriptional regulation

The "ZBTB3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets